HighTower Advisors
TMO icon

HighTower Advisors’s Thermo Fisher Scientific TMO Stock Holding History

HighTower Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$973 – 3978
2024
Q2 		$973 Sell
100
-300
-75% -$172K ﹤0.01% 3564
2024
Q1 		$460 Hold
400
– – ﹤0.01% 3549
2023
Q4 		$3.28K Buy
400
+389
+3,536% +$188K ﹤0.01% 3488
2023
Q3 		$9.57K Hold
11
– – ﹤0.01% 3388
2023
Q2 		$15.2K Sell
11
-1,489
-99% -$804K ﹤0.01% 3271
2023
Q1 		$19.1K Buy
1,500
+1,485
+9,900% +$837K ﹤0.01% 3150
2022
Q4 		$28.3K Buy
15
+14
+1,400% +$7.42K ﹤0.01% 3093
2022
Q3 		$4K Buy
+1
New +$560 ﹤0.01% 3067
2022
Q1 		– Sell
-1
Closed -$39K – 3682
2021
Q4 		$39K Buy
+1
New +$624 ﹤0.01% 3050
2020
Q2 		– Sell
-100
Closed -$4K – 2538
2020
Q1 		$4K Hold
100
– – ﹤0.01% 2153
2019
Q4 		$1K Hold
100
– – ﹤0.01% 2269
2019
Q3 		$1K Buy
+100
New +$28.6K ﹤0.01% 2397
2014
Q2 		– Sell
-100
Closed -$1K – 1711
2014
Q1 		$1K Buy
+100
New +$11.9K ﹤0.01% 1586

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HighTower Advisors's TMO Position: Q2 2026 in Review

HighTower Advisors increased its Thermo Fisher Scientific (TMO) stake by 9.8% in Q2 2026, buying an estimated $6.81M and bringing the position to 159,181 shares worth $79.8M. The position accounts for 0.08% of the portfolio, ranked #255.

HighTower Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $113M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • HighTower Advisors held 159,181 shares of Thermo Fisher Scientific worth $79.8M as of Q2 2026.
  • HighTower Advisors bought 14,180 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.81M.
  • Thermo Fisher Scientific made up 0.08% of HighTower Advisors's portfolio in Q2 2026, its #255 holding.
  • HighTower Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's Thermo Fisher Scientific position peaked at $113M in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.